TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Nuchev Pty Ltd ( (AU:NUC) ).
Nuchev Pty Ltd reported a record quarterly revenue of $6.3 million for Q4 FY25, marking a 167% increase from the previous corresponding period. The company’s expansion into the Vietnamese market and a new Sales Agency Agreement with Brauer Natural Medicines and H&S Brand Corporation have been pivotal in driving growth. Oli6® Nutritional sales, particularly in the ANZ and China CBEC markets, have shown significant increases, with the brand outperforming the overall infant formula market. The company aims to achieve breakeven through continued market expansion and strategic partnerships.
The most recent analyst rating on (AU:NUC) stock is a Hold with a A$0.14 price target. To see the full list of analyst forecasts on Nuchev Pty Ltd stock, see the AU:NUC Stock Forecast page.
More about Nuchev Pty Ltd
Nuchev Pty Ltd operates in the nutritional products industry, primarily focusing on the production and sale of Oli6® Nutritional products. The company targets markets in Australia, New Zealand, China, and Vietnam, with a strong emphasis on the infant formula category.
Average Trading Volume: 32,796
Technical Sentiment Signal: Sell
Current Market Cap: A$22M
See more insights into NUC stock on TipRanks’ Stock Analysis page.